CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event

About this update from D-box Technologies Inc. Class A

NEW YORK, NY / ACCESSWIRE / August 15, 2024 / CoCrystal Pharma (NASDAQ:COCP), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses and noroviruses, announces that management will present a company overview at the virtual Investor Summit Microcap Forum being held Tuesday, August 20, 2024. Management will be available for 1-on-1 meetings throughout the day. Qualified investors can register here to view the live presentation and to ask questions. Event: Q3 Investor Summit Date: August 20 th , 2024 Presentation Time: 9:00 a.m. ET (6:00 a.m. PT) Location: WEBCAST LINK The theme is 50 micro-cap companies with a catalyst and/or strong performance in the current market. Take a deep dive with the best Investors in MicroCap Live Q & A Complimentary to Qualified Investors. Please REGISTER HERE . About Cocrystal Pharma Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com . About the Investor Summit The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. Founded in 2015. Contact: Fred Rockwell [email protected] Investor Summit Group SOURCE: CoCrystal Pharma View the original press release on accesswire.com

View stock analysis, news, and events for D-box Technologies Inc. Class A